Quantcast

Latest Quinolone Stories

2014-08-06 08:32:23

LONDON, Aug. 6, 2014 /PRNewswire/ -- LON-ReportbuyerReportbuyer.com has added a new market research report:Antibacterial Drugs Market (By Class and Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019http://www.reportbuyer.com/pharma_healthcare/therapeutic/antibacterial_drugs_market_by_class_pipeline_analysis_global_industry_analysis_size_share_growth_trends_forecast_2013_2019.html Antibacterial Drugs Market (By Class - Aminoglycosides,...

2014-06-17 23:03:04

New research study “Antibiotics Partnering Terms and Agreements” worked out by CurrentPartnering is now available at MarketPublishers.com. London, UK (PRWEB) June 17, 2014 Antibiotics are antimicrobial compounds, used to treat a broad range of various bacterial infections in humans as well as animals and plants. Antibiotics have saved countess lives since their discovery. Antibiotics are effective against certain fungal and bacterial infections and are also used a treatment for...

2014-06-12 08:29:42

DUBLIN, June 12, 2014 /PRNewswire/ -- Research and Markets (http://www.researchandmarkets.com/research/l2jzql/antibacterial) has announced the addition of the "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 - 2019" report to their offering. http://photos.prnewswire.com/prnh/20130307/600769 This report on antibacterial drugs market studies the current as well as future prospects of the market globally. The market for antibacterial drugs...

2014-06-12 08:29:09

FAIRFIELD, N.J., June 12, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today that its licensor, Ferrer, has initiated the second Phase III clinical study for Ozenoxacin, a novel bactericidal non-fluorinated quinolone in development for impetigo. Ferrer, a privately-help Spanish pharmaceutical company, licensed US rights for Ozenoxacin to Medimetriks earlier this year. The multicenter, randomized, double-blinded, clinical study compares Ozenoxacin 1% cream...

2014-05-23 12:24:30

A Group of 50 Adverse Drug Reaction Victims Rally in Washington, DC Before Meeting with Members of Congress; Thousands Connect Via Online Support Groups Emerging Worldwide WASHINGTON, May 23, 2014 /PRNewswire-USNewswire/ -- A group of 50 Americans who call themselves "Floxies" because they each took the prescribed antibiotic medication Fluoroquinolone which they allege has had disastrous health consequences, have appealed to members of Congress for help in warning others. In their...

2014-05-16 23:07:27

Antibacterial Drugs Market: Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2013 - 2019 Albany, New York (PRWEB) May 16, 2014 Antibacterial Drugs Market was valued at USD 43.55billion in 2012 and is expected to grow at a CAGR of0.3% from 2013 to 2019, to reach an estimated value of USD 45.09billion in 2019. An antibacterial drug has been utilized by humans since the discovery of the first antibiotic penicillin in 1928 and has grown into a multi-billion dollar market...

2014-05-15 12:34:27

LONDON, May 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report: Antibacterial Drugs: World Market Prospects 2013-2023http://www.reportbuyer.com/pharma_healthcare/generic_drugs/antibacterial_drugs_world_market_prospects.html Report DetailsDiscover new trends, opportunities and revenue prospects for bacteria-killing medicinesWhere's the antibiotics market heading? How are those products performing? Visiongain's updated report gives you forecasted revenues...

2014-04-01 08:22:33

ALBANY, New York, April 1, 2014 /PRNewswire/ -- MRRBIZ includes new market research report "Antibacterial Drugs Market (By Class - Aminoglycosides, B-Lactams, Tetracyclines, Sulfonamides, Quinolones/ Fluoroquinolones, Macrolides And Phenicols, And Pipeline Analysis) - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2013 - 2019" to its large collection of research report. This report on antibacterial drugs market studies the current as well as future...

2014-03-26 16:25:09

DUBLIN, March 26, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/bn9wlv/antibacterial) has announced the addition of the "Antibacterial Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast to 2019" [http://www.researchandmarkets.com/research/bn9wlv/antibacterial ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) An antibacterial drug is referred to as an...

2014-03-24 08:29:42

FAIRFIELD, N.J., March 24, 2014 /PRNewswire/ -- Medimetriks Pharmaceuticals, Inc. announced today a licensing agreement with Ferrer, a privately-held Spanish pharmaceutical company, for the commercialization rights to Ozenoxacin 1% Cream in the United States. Ozenoxacin is a novel, bactericidal non-fluorinated quinolone in development as a topical treatment for impetigo. In 2013, Ferrer successfully completed the first Phase III Clinical Trial of Ozenoxacin in adult and pediatric...


Word of the Day
pungle
  • To take pains; labor assiduously with little progress.
This word comes from the Spanish 'pongale,' put it.
Related